Affluent Medical SAS Cash Flow-to-Debt Ratio
Affluent Medical SAS cash flow-to-debt ratio. Affluent Medical SAS (AFME) has a Cash Flow-to-Debt Ratio of -0.17x as of June 2025, meaning its operating cash flow of €-6.74 Million could theoretically repay 0% of its total liabilities (€38.73 Million) in one year. See Affluent Medical SAS (AFME) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Affluent Medical SAS (2016–2024)
Cash flow-to-debt ratio of Affluent Medical SAS from 2016 to 2024. Historical debt coverage capacity for Affluent Medical SAS across 8 annual periods. Also explore Affluent Medical SAS (AFME) equity growth momentum to track the company's year-over-year net asset growth rate.
Affluent Medical SAS Cash Flow-to-Debt Ratio by Year (2016–2024)
Affluent Medical SAS cash flow-to-debt ratio by year from 2016 to 2024. Year-by-year debt coverage analysis for Affluent Medical SAS. For the full cash flow conversion analysis, see how efficiently does Affluent Medical SAS generate cash.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.37x | €-11.32 Million | €30.59 Million | ▲ +22.8% |
| 2023 | -0.48x | €-12.05 Million | €25.15 Million | ▼ -13.3% |
| 2022 | -0.42x | €-11.08 Million | €26.19 Million | ▲ +9.3% |
| 2021 | -0.47x | €-12.36 Million | €26.50 Million | ▼ -54.2% |
| 2020 | -0.30x | €-8.94 Million | €29.54 Million | ▲ +14.9% |
| 2019 | -0.36x | €-12.19 Million | €34.29 Million | ▲ +80.3% |
| 2017 | -1.81x | €-10.84 Million | €6.00 Million | ▲ +52.4% |
| 2016 | -3.80x | €-10.84 Million | €2.85 Million | — |